These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 24592222)
41. Neural changes in Alzheimer's disease from circuit to molecule: Perspective of optogenetics. Yang Q; Song D; Qing H Neurosci Biobehav Rev; 2017 Aug; 79():110-118. PubMed ID: 28522119 [TBL] [Abstract][Full Text] [Related]
42. The Circuit Motif as a Conceptual Tool for Multilevel Neuroscience. Braganza O; Beck H Trends Neurosci; 2018 Mar; 41(3):128-136. PubMed ID: 29397990 [TBL] [Abstract][Full Text] [Related]
43. Toward Standardized Guidelines for Investigating Neural Circuit Control of Behavior in Animal Research. Lewis AS; Calipari ES; Siciliano CA eNeuro; 2021; 8(2):. PubMed ID: 33782101 [TBL] [Abstract][Full Text] [Related]
44. Optogenetic Approaches to Understand the Neural Circuit Mechanism of Social Deficits Seen in Autism Spectrum Disorders. Nakai N; Overton ETN; Takumi T Adv Exp Med Biol; 2021; 1293():523-533. PubMed ID: 33398839 [TBL] [Abstract][Full Text] [Related]
45. Miniaturized optogenetic neural implants: a review. Fan B; Li W Lab Chip; 2015 Oct; 15(19):3838-55. PubMed ID: 26308721 [TBL] [Abstract][Full Text] [Related]
46. Simultaneous high-speed imaging and optogenetic inhibition in the intact mouse brain. Bovetti S; Moretti C; Zucca S; Dal Maschio M; Bonifazi P; Fellin T Sci Rep; 2017 Jan; 7():40041. PubMed ID: 28053310 [TBL] [Abstract][Full Text] [Related]
47. Optogenetic Entrainment of Hippocampal Theta Oscillations in Behaving Mice. Bender F; Korotkova T; Ponomarenko A J Vis Exp; 2018 Jun; (136):. PubMed ID: 30010632 [TBL] [Abstract][Full Text] [Related]
49. Development of transgenic animals for optogenetic manipulation of mammalian nervous system function: progress and prospects for behavioral neuroscience. Ting JT; Feng G Behav Brain Res; 2013 Oct; 255():3-18. PubMed ID: 23473879 [TBL] [Abstract][Full Text] [Related]
50. Chronotherapeutic strategy: Rhythm monitoring, manipulation and disruption. Ohdo S Adv Drug Deliv Rev; 2010 Jul; 62(9-10):859-75. PubMed ID: 20188774 [TBL] [Abstract][Full Text] [Related]
51. Application of optogenetics and in vivo imaging approaches for elucidating the neurobiology of addiction. Vickstrom CR; Snarrenberg ST; Friedman V; Liu QS Mol Psychiatry; 2022 Jan; 27(1):640-651. PubMed ID: 34145393 [TBL] [Abstract][Full Text] [Related]
53. Optogenetic manipulation of neural activity in C. elegans: from synapse to circuits and behaviour. Husson SJ; Gottschalk A; Leifer AM Biol Cell; 2013 Jun; 105(6):235-50. PubMed ID: 23458457 [TBL] [Abstract][Full Text] [Related]
54. Understanding the circuit basis of cognitive functions using mouse models. Nakajima M; Schmitt LI Neurosci Res; 2020 Mar; 152():44-58. PubMed ID: 31857115 [TBL] [Abstract][Full Text] [Related]
55. Spotlight on movement disorders: What optogenetics has to offer. Rossi MA; Calakos N; Yin HH Mov Disord; 2015 Apr; 30(5):624-31. PubMed ID: 25777796 [TBL] [Abstract][Full Text] [Related]
56. Brain circuit dysfunction in specific symptoms of depression. Lv QY; Chen MM; Li Y; Yu Y; Liao H Eur J Neurosci; 2022 May; 55(9-10):2393-2403. PubMed ID: 33818849 [TBL] [Abstract][Full Text] [Related]
60. Role for the Clock gene in bipolar disorder. McClung CA Cold Spring Harb Symp Quant Biol; 2007; 72():637-44. PubMed ID: 18419323 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]